Identification of Potentially Potent Heme Oxygenase1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis

被引:31
作者
Floresta, Giuseppe [1 ,2 ]
Amata, Emanuele [1 ]
Dichiara, Maria [1 ]
Marrazzo, Agostino [1 ]
Salerno, Loredana [1 ]
Romeo, Giuseppe [1 ]
Prezzavento, Orazio [1 ]
Pittala, Valeria [1 ]
Rescifina, Antonio [1 ]
机构
[1] Univ Catania, Dept Drug Sci, Viale A Doria 6, I-95125 Catania, Italy
[2] Univ Catania, Dept Chem Sci, Viale A Doria 6, I-95125 Catania, Italy
关键词
3D-QSAR; heme oxygenase; HO-1; inhibitors; scaffold hopping; virtual screening; RAY CRYSTAL-STRUCTURE; QSAR; IMIDAZOLE; DERIVATIVES; MODEL; HO-1; DATABASE; ANALOGS; COMPLEX; COMFA;
D O I
10.1002/cmdc.201800176
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A 3D quantitative structure-activity relationship (3D-QSAR) model for predicting the activity of heme oxygenase1 (HO-1) inhibitors was constructed with the aim of providing a useful tool for the identification, design, and optimization of novel HO-1 inhibitors. The model was built using a set of 222 HO-1 inhibitors recovered from the Heme Oxygenase Database (HemeOxDB) and developed with the software Forge. The present model showed high statistical quality, as confirmed by its robust predictive potential and satisfactory descriptive capability. The drawn-up 3D map enables prompt visual comprehension of the electrostatic, hydrophobic, and shaping features underlying the interactions with HO-1 inhibitors. A theoretical approach for the generation of new lead compounds was performed by means of scaffold-hopping analysis. For the first time, a 3D-QSAR model is reported for this target, and was built with a number of chemically diverse HO-1 inhibitors; the model also accounts well for individual ligand affinities. The new model contains all of the inhibitors published to date with high potency toward the selected target and contains a complete pharmacophore description of the binding cavity of HO-1. These features will ensure application in accelerating the identification of new potent and selective HO-1 inhibitors.
引用
收藏
页码:1336 / 1342
页数:7
相关论文
共 56 条
[1]   Pharmacological and clinical aspects of heme oxygenase [J].
Abraham, Nader G. ;
Kappas, Attallah .
PHARMACOLOGICAL REVIEWS, 2008, 60 (01) :79-127
[2]   3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7 [J].
Alam, Sarfaraz ;
Khan, Feroz .
SCIENTIFIC REPORTS, 2017, 7
[3]   SUITABILITY OF THE MP3-DERIVED MOLECULAR ELECTROSTATIC POTENTIALS [J].
ALEMAN, C ;
LUQUE, FJ ;
OROZCO, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1993, 14 (07) :799-808
[4]   Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform1 Inhibitors [J].
Amata, Emanuele ;
Marrazzo, Agostino ;
Dichiara, Maria ;
Modica, Maria N. ;
Salerno, Loredana ;
Prezzavento, Orazio ;
Nastasi, Giovanni ;
Rescifina, Antonio ;
Romeo, Giuseppe ;
Pittala, Valeria .
CHEMMEDCHEM, 2017, 12 (22) :1873-1881
[5]  
Amata E, 2017, DATA BRIEF, V15, P281, DOI 10.1016/j.dib.2017.09.036
[6]   Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries [J].
Amata, Emanuele ;
Pittala, Valeria ;
Marrazzo, Agostino ;
Parenti, Carmela ;
Prezzavento, Orazio ;
Arena, Emanuela ;
Nabavi, Seyed Mohammad ;
Salerno, Loredana .
CLINICAL SCIENCE, 2017, 131 (14) :1701-1712
[7]  
[Anonymous], FORG VERS 10 4 2
[8]  
[Anonymous], MARVINSKETCH VERS 18
[9]   Nrf2 as regulator of innate immunity: A molecular Swiss army knife! [J].
Battino, Maurizio ;
Giampieri, Francesca ;
Pistollato, Francesca ;
Sureda, Antoni ;
de Oliveira, Marcos Roberto ;
Pittala, Valeria ;
Fallarino, Francesca ;
Nabavi, Seyed Fazel ;
Atanasov, Atanas Georgiev ;
Nabavi, Seyed Mohammad .
BIOTECHNOLOGY ADVANCES, 2018, 36 (02) :358-370
[10]   The ChEMBL bioactivity database: an update [J].
Bento, A. Patricia ;
Gaulton, Anna ;
Hersey, Anne ;
Bellis, Louisa J. ;
Chambers, Jon ;
Davies, Mark ;
Krueger, Felix A. ;
Light, Yvonne ;
Mak, Lora ;
McGlinchey, Shaun ;
Nowotka, Michal ;
Papadatos, George ;
Santos, Rita ;
Overington, John P. .
NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) :D1083-D1090